GS-100 so rekombinant AAV9 vector ya mangikododod human NGLY1 gene. Naawat na orphan drug designation na US Food and Drug Administration tan European Medicine Agency (EMA) Say therapy so akaawat met na FDA's rare pediatric disease designation nen 2021 tan fast track designation nen imbeneg ya taon.